An organ-on-chip platform equipped with microsensors for long-term microfluidic cultivation and metabolic monitoring (O 2 , Glu, Lac) of 3D tumour organoid cultures grown from patient-derived single cancer stem cells.
No takes yet. Share an insight, caveat, or question.
Dornhof et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: